Fintech’s Great Reappraisal

Fintech’s Great Reappraisal

Sarah Lamont is an Associate at F-Prime Capital, where she focuses on early-stage investments in fintech.

Read More

Building startups as a VC with Team8

Building startups as a VC with Team8

In an interview with The Financial Revolutionist, Team8 Partner Liran Amrany describes Team 8’s mission, makes the case for VCs building—rather than just giving money to—promising startups, and outlines the operational steps that make this investment strategy a success.

Read More

Three regulatory questions shaping fintech VC

Three regulatory questions shaping fintech VC

A confluence of regulatory variables affect the quality and quantity of capital available for fintechs in 2023.

Read More

Marketing three times with Percent

Marketing three times with Percent

According to Jessica Zall, Chief Marketing Officer at Percent, the startup is unique from other private-credit and fundraising platforms by bringing all three market participants together—underwriters, borrowers, and investors—and not just a subset thereof.

Read More

A pitch for early-stage fintech with Cambrian

A pitch for early-stage fintech with Cambrian

According to Rex Salisbury, Founder and General Partner at Cambrian, capital and labor conditions make it a particularly promising time to invest in early-stage fintech startups. 

Read More

Why are older women invisible to HealthTech?

Why are older women invisible to HealthTech?

Sharon Carothers leads the SensisHealth practice after two decades of consulting and leadership positions at The Lewin Group, American Legacy Foundation (now Truth Initiative), and Booz Allen Hamilton.

Read More

The future of healthcare-focused fintechs with Distributed Ventures

The future of healthcare-focused fintechs with Distributed Ventures

According to Shawn Ellis, Managing Partner at Distributed Ventures, the marriage of fintech and healthcare can fundamentally alter how the medical sector operates and how patients navigate the healthcare space.

Read More

When medical and financial regulations meet

When medical and financial regulations meet

When money and medicine intertwine, compliance becomes notably complicated and demanding. But there are opportunities for fintechs where these regulatory obligations meet.

Read More